Despite its preventability, lead poisoning remains a common pediatric problem (1) (2) (3) . Lead primarily affects three target organs in children: brain, kidney, and blood-forming organs (4) . Lead is especially toxic for young children (4) (5) (6) (7) (8) . Immature organs are most susceptible to damage at their time of most rapid growth, accounting for the observation that the brain is most vulnerable in the first 2 years of life (8) . The blood-brain barrier takes 3 years to complete development; therefore, lead ingested by toddlers enters the central nervous system more readily (3) (4) (5) (6) (7) . Furthermore, absorption and bioavailability of ingested lead is four times greater in children than in adults--40% versus 10%. Risk of lead ingestion is increased in young children by pica and normal handto-mouth exploratory behavior (5) (6) (7) (8) (9) . In 1990, the EPA estimated that 3 million of the nation's children under 6 years of age had blood lead levels >10 pig/dl, the level statistically associated with subsequent lower intellectual performance and other adverse health effects (10) (11) (12) (13) (14) . Not only can leadintoxicated children have impaired intelligence but they also are frequently overactive, aggressive, more distractible, disorganized, and less able to follow directions (15) (16) (17) .
Longitudinal studies of young children with high lead levels have shown lower class standing in the final year of high school, with increased absenteeism, lower vocabulary scores, and impaired motor function (8, 18) . The sources and pathways of lead exposure are well enough known that serious preventive efforts intended to eradicate childhood lead toxicity are now under way (4) (5) (6) 9, 14, 18 (21) . In October 1991, the Centers for Disease Control and Prevention (CDC) set the current level for acceptable blood lead concentration at <10 pg/dl, a level believed not to be harmful to children (5) . In October 1992, the Texas Department of Health Laboratories began using a graphite furnace atomic absorption spectrophotometer (GFAAS) analytic method, which allowed more accurate determination of blood lead concentrations at these lower levels (22) .
The aim of this study was to determine demographic risk factors for high lead levels in Texas children tested during routine Medicaid screening, and it focused on gender, ethnicity, and age.
Design
The study population consisted of all the Texas children covered by Medicaid screened for blood lead for 6 months (1 January-30 June 1993). The specimens were collected by well-child clinics in local health departments and by office-based private physicians. Samples were either venous or capillary specimens, at the physician's discretion. Program guidelines request that all follow-up specimens be venous in order to reduce the possibility of skin lead contamination, which may occur with poorly collected capillary specimens. Venous specimens for verification of initial high results were requested at 3-month intervals following therapeutic intervention. All specimens were analyzed by the Texas Department of Health (TDH) laboratory in Austin, Texas, using GFAAS methodology (22. Submitters received laboratory reports 7-10 days after specimen collection.
Age of subjects was imputed as the difference between date of birth and 30 June 1993, the last date of the 6-month collection period. The dates of specimen collection were not included in the magnetic data file made available for this study so exact ages of subjects were not available for this study.
Analysis Age (months) Figure 1 . Percent of abnormal blood specimens from Texas children covered by Medicaid by age and lead concentration, January through June 1993. *Denotes the number of children in that category. (23) (24) (25) . There were significant but complex associations between income, ethnicity, and lead concentration. There was a stronger inverse relation between income and lead levels in African Americans than in whites. About one-sixth (18.5%) of African American children from low-income households (less than $6,000/year) had blood lead concentrations high enough to qualify for medical follow-up (23) (24) (25) .
Phase I of the NHANES III survey took place from October 1988 through October 1991 and showed a 78% decline in the estimated geometric mean in blood lead levels in the U.S. population (26) (27) (28) .
This decrease was similar across all age groups, leaving the cross-sectional age pattern virtually unchanged (26) (27) (28) 
